STREP Flashcards

(30 cards)

1
Q

What are the General Features of Streptococci (with “why”)

A
  • Gram-positive, catalase-negative cocci

➡️ Lacks catalase enzyme, unlike staphylococci; helps differentiate them in the lab.

  • Oval or coccoid cells (\~2 µm), arranged in pairs or chains

➡️ “Strepto-” means twisted chain; typical microscopic appearance.

  • Facultative anaerobes or capnophilic

➡️ Can grow with or without oxygen; some prefer CO₂-rich environments, helping survival in various host tissues.

  • Homofermentative metabolism (produces lactic acid without gas)

➡️ End-product of glucose metabolism is lactic acid, which can contribute to local tissue damage or acidification.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What’s the Taxonomy of streptococcus?

A
  • Kingdom: Eubacteria
  • Phylum: Firmicutes
  • Class: Bacilli
  • Order: Lactobacillales
  • Family: Streptococcaceae
  • Genus: Streptococcus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classify streptococcus bacteria with examples of each

A

Classification Methods (with “why”)

  1. Hemolytic Reaction on Blood Agar

➡️ Shows how the bacteria interact with red blood cells:

  • Beta-hemolysis: Complete lysis ⏩clear zone (e.g., S. pyogenes)
  • Alpha-hemolysis: Partial lysis ⏩ greenish zone (e.g., S. pneumoniae)
  • Gamma-hemolysis: No lysis (e.g., some enterococci)

Why it matters: Hemolysis helps quickly narrow down species groups.

  1. Lancefield Grouping (A–H, K–U)

➡️ Based on specific carbohydrate antigens in the cell wall.

  • Group A: S. pyogenes
  • Group B: S. agalactiae

Why it matters: Helps identify pathogens responsible for different infections.

  1. Capsular Polysaccharide Typing

➡️ Used especially for S. pneumoniae (over 90 serotypes) and Group B strep.

Why: Capsule determines virulence and immunity; typing aids in vaccine development.

  1. Biochemical Reactions

➡️ Needed when antigen-based grouping fails.

  • Used for identifying viridans group streptococci and others that don’t fit Lancefield types.

Why: Viridans strep lack Lancefield antigens but cause diseases like endocarditis; require alternative ID methods.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List examples of medically relevant streptococcus

A
  1. Streptococcus pyogenes (Group A β-haemolytic streptococcus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the core characteristics of Streptococcus pyogenes (Group A β-haemolytic streptococcus)

A
  • Gram-positive cocci, 0.6–1.0 µm, arranged in chains.
  • Beta-haemolytic on blood agar → complete RBC lysis.
  • Group A (Lancefield antigen).
  • Natural reservoir: Humans.
  • Transmission: Person-to-person via respiratory droplets.
  • Peak age: 5–15 years (pharyngitis most common).

Molecular Typing

  • >150 strains identified based on M-protein types.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Carriage Rates

  • Pharyngeal carriage in children: 15–20% (varies by season/location).
  • Lower in adults → natural immunity or reduced exposure .
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the Virulence Factors S. Pyognes(with clinical “why”)

A

1. Surface Structures

  • Hyaluronic acid capsule

⏩ Mimics host tissues, inhibits phagocytosis.

  • Lipoteichoic acid

⏩ Promotes initial adherence to pharyngeal cells.

  • M-protein (major virulence factor)
  • Inhibits complement activation (antiphagocytic).
  • Facilitates adherence to mucosa.

⏩ Correlates with invasiveness and immune evasion.

  • Adhesins (Fibronectin-binding proteins)

⏩ Promote tight attachment to epithelial surfaces.

  • Opacity factor

⏩ M-protein–linked, binds fibronectin; contributes to invasion and immune modulation.

2. Toxins

  • Streptolysin O (SLO)
  • Oxygen-labile, antigenic, best detected anaerobically.
  • Pore-forming; lyses RBCs, WBCs.
  • Streptolysin S (SLS)
  • Oxygen-stable, non-antigenic, causes beta-hemolysis on agar.
  • Damages host cell membranes.
  • Streptococcal pyrogenic exotoxins (SpeA, B, C…)
  • Superantigens ➡️ massive cytokine release.
  • Cause:
  • Toxic shock syndrome
  • Necrotizing fasciitis
  • Scarlet fever rash

3. Enzymes

  • DNases (A–D) ➡️ liquefy pus (reduce viscosity of neutrophil DNA).
  • Streptokinase ➡️ activates plasminogen ➡️ dissolves fibrin clots.
  • Hyaluronidase ➡️ degrades connective tissue; promotes spread.
  • C5a peptidase ➡️ cleaves C5a, inhibits PMN recruitment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical Takeaway

  • S. pyogenes uses a multi-pronged attack:
  • Evades immunity (capsule, M-protein).
  • Adheres and invades (adhesins, enzymes).
  • Destroys tissues and immune cells (toxins, haemolysins).
  • Spreads rapidly (streptokinase, hyaluronidase, DNases).
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical significance of Streptococcus pyogenes

A

1. Streptococcal Pharyngitis

  • Onset: Abrupt; 2–4 days post-exposure.
  • Features: Fever, headache, sore throat, malaise, gray-white tonsillar exudate.
  • Why: Local infection of pharyngeal mucosa; inflammation + toxin-mediated symptoms.

2. Scarlet Fever

  • Cause: Spe exotoxins (superantigens).
  • Rash: Diffuse, red, starts upper chest ➡️ spreads to trunk/extremities.
  • Why: Immune response to circulating exotoxins.

3. Toxic Shock–Like Syndrome (STSS)

  • Features: Bacteremia + necrotizing fasciitis, shock, multiorgan failure.
  • Cause: Superantigen (SpeA).
  • Why: Cytokine storm due to non-specific T-cell activation.

4. Puerperal Sepsis

  • Postpartum: Endometritis, sepsis, necrotizing fasciitis, TSS.
  • Neonates: Stillbirth, neonatal sepsis, cellulitis.
  • Complications: Pelvic cellulitis, peritonitis, abscess.
  • Why: Invasion of genital tract mucosa during delivery.

5. Impetigo

  • Features: Vesicles ➡️ pustules ➡️ crusted lesions.
  • Common in: Children.
  • Why: Superficial skin infection from minor trauma or insect bites.

6. Cellulitis

  • Features: Red, warm, swollen spreading skin infection.
  • Why: Infection of dermis/subcutis; often follows skin injury.

7. Erysipelas

  • Distinct feature: Sharply demarcated skin swelling + fever.
  • Why: Lymphatic spread of infection; involves superficial dermis and lymphatics.

8. Non-Suppurative Sequelae

Acute Rheumatic Fever (ARF)

  • Triggered by: Pharyngitis (M1, 3, 5, 6, 14, 18, 19).
  • Why: Molecular mimicry ➡️ autoimmune attack on heart, joints, CNS.

Acute Glomerulonephritis (AGN)

  • Triggered by: Skin (M2, 9, 55, 57, etc.) or pharyngeal infection (M1, 4, 12…).
  • Why: Immune complex deposition in glomeruli ➡️ inflammation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the Basic Characteristics of Streptococcus pneumoniae (Pneumococcus)

A
  • Gram-positive, alpha-hemolytic, lancet-shaped diplococcus.
  • Capsulated: >92 serotypes; capsule is the major virulence factor.
  • Reservoir: Human nasopharynx.
  • Transmission: Respiratory droplets.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Carriage & Risk Factors of Pneumococcus

  • High carriage: 70–100% in infants; decreases with age (\~10% in adults).
  • Invasive risk: <2yrs, >65yrs, immunocompromised, chronic diseases.
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the Virulence Factors & Function of pneumococcus

A

| Capsular polysaccharide ➡️ Inhibits phagocytosis; key for invasion

Cell wall polysaccharide ➡️Triggers inflammation via cytokine and complement activation |
Pneumolysin ➡️ Cytotoxic; damages cilia, activates complement
PspA & PspC ➡️Inhibit complement binding and phagocytosis
PsaA ➡️Promotes adhesion to mucosal cells
Autolysin ➡️Lyses bacteria to release inflammatory components
Neuraminidases (NanA, NanB) ➡️Aid adherence, especially in respiratory tract

Factor | Function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical significance of S. Pneumonia

A

1. Community-Acquired Pneumonia (CAP)

  • Most common cause.
  • Presentation: Sudden fever, productive cough, pleuritic chest pain, consolidation.
  • Why: Inhaled or aspirated into alveoli ➡️ inflammation, consolidation.

2. Bacterial Meningitis

  • Leading cause in adults and children <5yrs.
  • Why: Nasopharyngeal colonization ➡️ bloodstream ➡️ meningeal invasion.

3. Otitis Media, Sinusitis, Mastoiditis

  • Accounts for \~40–50% of acute otitis media in children.
  • Why: Eustachian tube dysfunction allows migration from nasopharynx.

4. Bacteremia/Sepsis

  • Often follows pneumonia or otitis media in high-risk groups.

5. Less Common Infections

  • Endocarditis, pericarditis, arthritis, osteomyelitis, neonatal sepsis, skin/soft tissue infections.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the Age-Related Serotype Patterns of S. Pneumonia?

A
  • Children: 6, 14, 18, 19, 23.
  • Adults: 1, 3, 4, 7, 8, 12.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the key characteristics of III. Streptococcus agalactiae (GBS)

A
  • Gram-positive, beta-hemolytic, Group B Streptococcus.
  • Colonizes vagina, rectum, and GI tract.
  • Higher colonization in Black women, DM, immunosuppressed.
  • Transmission: Maternal ➡️ neonatal (in utero or during delivery).
  • Group B antigen: Acid-stable rhamnose-glucosamine polymer.
  • Capsular serotypes: Ia, Ib, II–VIII.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Whatre the Virulence Factors of Streptococcus agalactiae (GBS)

A

Capsule ➡️ Inhibits phagocytosis and complement activation

| Sialic acid ➡️Blocks alternate complement pathway

| Beta-hemolysin/cytolysin ➡️Damages lung/endothelial cells; aids CNS invasion

| Lipoteichoic acid ➡️Promotes epithelial adherence

| C5a peptidase ➡️Disrupts neutrophil recruitment

| c-antigen proteins ➡️Promote invasion of cervical cells, protect intracellularly

| Others ➡️➡️Hyaluronidase, CAMP factor, proteases, nucleases

Factor | Function

17
Q

What are the Clinical Significance GBS

A

Neonatal Disease

  • Early-onset (<7 days): Sepsis, pneumonia, meningitis.
  • Late-onset (7–89 days): Sepsis, meningitis, focal infections (e.g., bone, joints).

Adults

  • Risk factors: Immunosuppression, comorbidities.
  • Diseases: Pneumonia, septic arthritis, osteomyelitis, endocarditis, meningitis, soft tissue infections.

Women

  • UTI, postpartum endometritis, post-Caesarean bacteraemia.
18
Q

What are the key features of Viridans Streptococci

A

Key Features

  • Alpha or non-hemolytic, gram-positive cocci.
  • Normal flora: Mouth, respiratory, urogenital tracts.
  • its of Low virulence, but opportunistic.
19
Q

What are the conditions Viridian can cause and it’s mechanism

A

| Dental caries (S. mutans) ⏩Glucosyltransferases ➡️ which hydrolyse dietary sucrose, form insoluble glucans that adhere to teeth ➡️dental plaque

| Infective endocarditis ⏩Especially in damaged valves (e.g., rheumatic heart disease) |

| Bacteraemia ⏩In neutropenic patients |

| Meningitis ⏩ In congenital craniofacial abnormalities or head trauma

Condition | Mechanism

20
Q

What are the Classification Groups of S. Viridian?

A

Classification Groups

Group Species

Mitis ➡️ S. mitis, S. oralis, S. infantis, etc.

Mutans ➡️ S. mutans, S. sobrinus, etc.

Salivarius ➡️ S. salivarius, S. thermophilus, etc.

Sanguinis ➡️ S. sanguinis, S. gordonii, etc.

Anginosus ➡️ S. anginosus, S. intermedius, etc.

Bovis ➡️ S. gallolyticus, S. pasteurianus, etc.

21
Q

Based on the different infection type how are samples collected in STREP?

A

| Pharyngitis ➡️Depress tongue, swab posterior pharynx and tonsils. Avoid tongue/uvula contact.

| GBS screening ➡️Vaginal + rectal swab at 35–37 weeks gestation. Cervical swabs not useful.

| Meningitis ➡️Lumbar puncture using aseptic technique.

| Bacteraemia/sepsis ➡️Blood cultures. Multiple sets improve yield.

| Lung infections ➡️Collect good-quality sputum (low epithelial cells, high neutrophils).

| Wound infections ➡️Priority: Tissue biopsy > Aspirate > Swab. Use aseptic technique.

Infection Type | Sample & Notes

22
Q

How do you culture STREP?

A

Media ⏩ Sheep Blood Agar (SBA) or Chocolate Agar for fastidious growth.

Incubation ⏩ 24–48 hours at 35–37°C, CO₂-enriched environment.

Haemolysis ⏩ Observe under anaerobic conditions: beta (clear), alpha (green), gamma (none), or alpha-prime.

Microscopy (Direct Gram Stain)

Appearance: Gram-positive cocci in pairs and chains.

Seen in specimens that later yield Streptococci on culture.

23
Q

What are the Presumptive Identification Methods for GAS

A

1. Group A Streptococcus (GAS – S. pyogenes)

  • Bacitracin Susceptibility
  • Positive test = any zone of inhibition on blood agar.
  • GAS is bacitracin-sensitive (used for presumptive ID).
  • SXT Susceptibility
  • GAS is SXT-resistant.
  • Helps exclude other beta-hemolytic groups (C, F, G are SXT-sensitive).
  • PYR Test
  • GAS is PYR-positive (red color after hydrolysis).
  • Highly sensitive and specific.
24
Q

What are the Presumptive Identification Methods for GBS

A

2. Group B Streptococcus (GBS – S. agalactiae)

  • CAMP Test
  • GBS produces arrowhead hemolysis when streaked near beta-hemolysin-producing S. aureus.
  • Highly sensitive for GBS.
  • Pigment Production
  • GBS may produce orange/red pigment (less commonly used diagnostically).
  • SXT Resistance
  • GBS is SXT-resistant, like GAS.
25
What are the **Presumptive Identification Methods for GDS**
**3. Group D Streptococci / Enterococci** * **Bile-Esculin Test**   * **Positive** = blackening of medium within 24 hours.   * Organisms can grow in **40% bile** and hydrolyze esculin. * **PYR Test**   * **Enterococci are PYR-positive**, like GAS.
26
What are the **Presumptive Identification Methods for Streptococcus pneumoniae**
**4. *Streptococcus pneumoniae*** * **Optochin Susceptibility**   * **Positive** = ≥14 mm zone of inhibition on blood agar.   * S. pneumoniae is **optochin-sensitive**; viridans streptococci are resistant. * **Bile Solubility Test**   * **Positive** = colony disintegration due to autolysis (via bile salt activation). * **Quellung Reaction (Capsular Swelling Test)**   * Uses specific **antisera** to detect capsular swelling = confirms serotype.
27
**5. Serologic Identification** * **Beta-hemolytic Streptococci (GAS, GBS, etc.)**   * Tests: **Capillary precipitin**, **Coagglutination**, **Latex agglutination**.   * Used to group beta-hemolytic streptococci (Lancefield groups A–G). * **S. pneumoniae**   * Detect capsular polysaccharide in CSF, urine via **coagglutination** or **latex agglutination**.
28
What are the **Treatment** Therapies for Strep Severe pneumonia Toxic shock syndrome Impetigo (Topical skin infection)
**First-line therapy** * **Penicillin**: Drug of choice for most streptococcal infections (including GAS, GBS, viridans). **Alternatives and indications** * **Ceftriaxone / Cefotaxime (IV)**:   * Used in **pneumococcal infections** due to rising penicillin resistance. * **Beta-lactam + Macrolide** combo:   * Improves outcomes in **severe pneumococcal pneumonia**. * **Other options**:   * **Clindamycin**: Useful in **toxin suppression** (e.g., toxic shock syndrome).   * **Vancomycin**: For **penicillin-resistant** strains or beta-lactam allergy.   * **Meropenem, macrolides**: Used based on susceptibility. **Supportive and surgical management** * **Fluids, ICU, ventilator**: Severe pneumonia, streptococcal toxic shock syndrome (STSS). * **Surgical debridement**: For **necrotizing fasciitis**, **myonecrosis**. **Topical agents for skin infections** * **Bacitracin**, **mupirocin**, **retapamulin**: Used for **impetigo**.
29
What are the **Preventive ** ways of strep
**General measures** * **Good dental and personal hygiene** * **Avoid animal contact** (specific zoonotic strains) **Antimicrobial prophylaxis** * **Dental/surgical procedures** in:   * Patients at high risk for **endocarditis**   * **Neutropenic patients** * **IM Benzathine penicillin** monthly:   * For **rheumatic fever prophylaxis** and in **army recruits** * **Penicillin within 9 days** of streptococcal pharyngitis:   * Prevents **rheumatic fever** * **Intrapartum antibiotic prophylaxis**:   * In GBS-colonized women during **labour** to prevent **neonatal GBS disease**
30
What are the **Vaccines** for strep
**Pneumococcal vaccines** * **PPSV23**:   * 23 capsular types (e.g., 1–5, 6B, 14, 19F, 23F, etc.)   * For **adults and high-risk groups** * **PCV7**:   * Serotypes: 4, 6B, 9V, 14, 18C, 19F, 23F   * Given at **2, 4, and 6 months** of age * **PCV13**:   * Covers **13 pediatric serotypes**   * > 90% protection in children **GBS vaccine** * **Glycoconjugate vaccine** currently **in clinical trials**